Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Shares Repurchased: 2012-2025

Historic Shares Repurchased for Ani Pharmaceuticals (ANIP) over the last 5 years, with Sep 2025 value amounting to $1.0 million.

  • Ani Pharmaceuticals' Shares Repurchased rose 53.53% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 9.60%. This contributed to the annual value of $11.0 million for FY2024, which is 119.75% up from last year.
  • As of Q3 2025, Ani Pharmaceuticals' Shares Repurchased stood at $1.0 million, which was up 89.47% from $551,000 recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Shares Repurchased peaked at $10.0 million during Q1 2025, and registered a low of $1,000 during Q4 2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Shares Repurchased value was $680,000 (recorded in 2024), while the average stood at $2.5 million.
  • Its Shares Repurchased has fluctuated over the past 5 years, first surged by 11,800.00% in 2022, then crashed by 57.62% in 2025.
  • Quarterly analysis of 5 years shows Ani Pharmaceuticals' Shares Repurchased stood at $1,000 in 2021, then surged by 11,800.00% to $119,000 in 2022, then skyrocketed by 94.12% to $231,000 in 2023, then soared by 37.66% to $318,000 in 2024, then skyrocketed by 53.53% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $551,000 for Q2 2025, and $10.0 million during Q1 2025.